Skip to content

Dose-response of Anteroposterior Mobilizations in Weight Bearing Talus Dorsiflexion

Dose-response of Anteroposterior Mobilizations in Weight Bearing Talus Dorsiflexion in the Older Adult: Allegorized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04563663
Acronym
ANKLE_WBROM
Enrollment
62
Registered
2020-09-24
Start date
2020-10-01
Completion date
2020-12-16
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging Problems

Keywords

Weight Bearing Dorsiflexion, Manual Therapy, Ankle, Dose-response

Brief summary

Ankle mobility limitations are common in older adults. A possible treatment to restore joint mobility is manual therapy based on mobilization techniques, in this case, applied on the ankle joint. Previous research had proposed different treatment volumes (one to twelve sessions), but shown a different and non-consistent degree of effectiveness according to such factor. Therefore, this work aims to determine the dose-response relationship of manual therapy (talus mobilizations) on ankle range of motion in the older adult.

Interventions

PROCEDUREPosteriorization of the talus.

Three sets of a 30-s grade IV anteroposterior mobilization.

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Community-dwelling older adults. * Limited ankle mobility (\< 35 degrees). * Over 60 years.

Exclusion criteria

* Not willing to participate or signing a consent form * Lower limb injury in the three months prior to the study (ex. sprain) * Diagnosed condition that may influence mobility assessments (i.e. stroke)

Design outcomes

Primary

MeasureTime frameDescription
Treatment doseChange from baseline to end of intervention (2 weeks) and follow-up (10 weeks)Number of sessions of experimental intervention needed to induce a clinically important gain in ankle mobility after the intervention. A baseline progression over 4.6º in the Lunge test will be considered clinically important (Powden, 2015), so that the number of sessions will be established when this threshold is exceeded (see secondary outcome) .

Secondary

MeasureTime frameDescription
The Lunge testChange from baseline, to end of intervention (2 weeks) and follow-up (10 weeks)Weight bearing ankle dorsiflexion range of motion. This test will measure the maximum tilt of the tibia that a subject can perform while standing and bearing the weight on the limb without lifting the heel from the floor. A Baseline® Digital Inclinometer (Fabrication Enterprises Inc) will be used to assessed this outcome. Values below 35º indicate limited mobility. A baseline progression over 4.6º will be considered clinically important (Powden, 2015). This mobility gain will be used to determine the dose-response relationship: number of sessions of talus mobilizations needed to induce a clinically important gain in ankle mobility after the intervention (see primary outcome measure)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026